INDICAID® Fentanyl Rapid Detection Test

Detect fentanyl in powder samples in just one minute with more than 99% accuracy. Designed to support harm reduction, rehabilitation, and community safety efforts.

For harm reduction use
>99% accuracy at 50% above and 50% below cut-off concentration

About

INDICAID Fentanyl Rapid Detection Test is a rapid chromatographic immunoassay for the qualitative screening of xylazine in powder at a cut-off concentration of 10 ng/mL in the test specimen. This assay provides only a preliminary, qualitative result.

Features

Results after 1 minute
>99% accuracy and 10 ng/mL sensitivity
Detects fentanyl in powder form
Compact, easy-to-use test strip design
Ideal for point-of-use settings—no lab equipment required

Who it's for

Harm reduction programs – Community groups and non-profits promoting safer substance use and drug-checking initiatives.
Public health departments – State and local agencies addressing opioid and xylazine-related health risks.
Rehabilitation and recovery centers – Facilities supporting substance use treatment and safety screening.
Clinical and academic researchers – Professionals studying drug trends, contamination, and harm reduction efficacy.

Ready to learn more?

Contact Sales or Request a sample

Specifications

Contents	Individually wrapped test strips, instructions for use, quick reference guide
Tests per kit	50 / Custom
Specimen type	Powder diluted in water
Time to result	1 minute
Cutoff concentration	10 ng/mL
Sensitivity	% agreement versus GC/MS at 500 ng/mL cut-off Sensitivity (PPA): 95.1% Specificity (NPA): 98.7%
Storage Condition	Store at 35-86°F (2-30°C); do not freeze; keep dry and away from sunlight
Shelf Life	24 months

Intended Use

INDICAID Fentanyl Rapid Detection Test is a rapid powder screening test that can be performed without the use of an instrument.
The test uses antibody to selectively detect elevated levels of xylazine in powder. INDICAID Fentanyl Rapid Detection Test yields a positive result when the xylazine in powder exceeds 10 ng/mL.

This assay provides only a qualitative, preliminary test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.